Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Jefferson Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Albany Molecular Research Inc raises FY 2014 earnings guidance

Tuesday, 6 May 2014 08:00am EDT 

Albany Molecular Research Inc:Increases FY 2014 adjusted EPS guidance to $0.78-$0.84 to reflect addition of Cedarburg Pharmaceuticals and strengthening contract business.Expects FY 2014 adjusted EBITDA between $54 mln and $60 mln.FY 2014 EPS of $0.79 and EBITDA of $59 mln - Thomson Reuters I/B/E/S. 

Company Quote

0.05 +0.33%
24 Dec 2014